Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)

BACKGROUND: There is growing evidence supporting multidisciplinary molecular tumor boards (MTB) in solid tumors whereas hematologic malignancies remain underrepresented in this regard. OBJECTIVE: The present study aimed to assess the clinical relevance of MTBs in primary refractory diffuse large B-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Witte, Hanno M., Riedl, Jörg, Künstner, Axel, Fähnrich, Anke, Ketzer, Julius, Fliedner, Stephanie M. J., Reimer, Niklas, Bernard, Veronica, von Bubnoff, Nikolas, Merz, Hartmut, Busch, Hauke, Feller, Alfred, Gebauer, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517902/
https://www.ncbi.nlm.nih.gov/pubmed/37488307
http://dx.doi.org/10.1007/s11523-023-00983-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517902/
https://www.ncbi.nlm.nih.gov/pubmed/37488307
http://dx.doi.org/10.1007/s11523-023-00983-5

Ejemplares similares